Pulmonary fibrosis is a progressive, dysregulated response to injury culminating in compromised lung function due to excess extracellular matrix production. The heparan sulfate proteoglycan syndecan-4 is important in mediating fibroblast-matrix interactions, but its role in pulmonary fibrosis has not been explored. To investigate this issue, we used intratracheal instillation of bleomycin as a model of acute lung injury and fibrosis. We found that bleomycin treatment increased syndecan-4 expression. Moreover, we observed a marked decrease in neutrophil recruitment and an increase in both myofibroblast recruitment and interstitial fibrosis in bleomycin-treated syndecan-4–null (Sdc4–/–) mice. Subsequently, we identified a direct interaction between CXCL10, an antifibrotic chemokine, and syndecan-4 that inhibited primary lung fibroblast migration during fibrosis; mutation of the heparin-binding domain, but not the CXCR3 domain, of CXCL10 diminished this effect. Similarly, migration of fibroblasts from patients with pulmonary fibrosis was inhibited in the presence of CXCL10 protein defective in CXCR3 binding. Furthermore, administration of recombinant CXCL10 protein inhibited fibrosis in WT mice, but not in Sdc4–/– mice. Collectively, these data suggest that the direct interaction of syndecan-4 and CXCL10 in the lung interstitial compartment serves to inhibit fibroblast recruitment and subsequent fibrosis. Thus, administration of CXCL10 protein defective in CXCR3 binding may represent a novel therapy for pulmonary fibrosis.
Dianhua Jiang, Jiurong Liang, Gabriele S. Campanella, Rishu Guo, Shuang Yu, Ting Xie, Ningshan Liu, Yoosun Jung, Robert Homer, Eric B. Meltzer, Yuejuan Li, Andrew M. Tager, Paul F. Goetinck, Andrew D. Luster, Paul W. Noble
Title and authors | Publication | Year |
---|---|---|
FOXF1 Inhibits Pulmonary Fibrosis by Preventing CDH2-CDH11 Cadherin Switch in Myofibroblasts
M Black, D Milewski, T Le, X Ren, Y Xu, VV Kalinichenko, TV Kalin |
Cell Reports | 2018 |
Signaling Mechanisms of Myofibroblastic Activation: Outside-in and Inside-Out
J Zent, LW Guo |
Cellular Physiology and Biochemistry | 2018 |
Overview of the Mechanisms that May Contribute to the Non-Redundant Activities of Interferon-Inducible CXC Chemokine Receptor 3 Ligands
M Metzemaekers, V Vanheule, R Janssens, S Struyf, P Proost |
Frontiers in immunology | 2018 |
Syndecan-2 Attenuates Radiation-induced Pulmonary Fibrosis and Inhibits Fibroblast Activation by Regulating PI3K/Akt/ROCK Pathway via CD148
K Tsoyi, SG Chu, NG Patino-Jaramillo, J Wilder, J Villalba, M Doyle-Eisele, J McDonald, X Liu, S El-Chemaly, MA Perrella, IO Rosas |
American journal of respiratory cell and molecular biology | 2018 |
Interplay between EZH2 and G9a Regulates CXCL10 Gene Repression in Idiopathic Pulmonary Fibrosis
WR Coward, OJ Brand, A Pasini, G Jenkins, AJ Knox, L Pang |
American journal of respiratory cell and molecular biology | 2018 |
Inflammatory signature in lung tissues in patients with combined pulmonary fibrosis and emphysema
WD Cornwell, C Kim, AC Lastra, C Dass, S Bolla, H Wang, H Zhao, FV Ramsey, N Marchetti, TJ Rogers, GJ Criner |
Biomarkers | 2018 |
Pulmonary immunity and extracellular matrix interactions
DN O'Dwyer, SJ Gurczynski, BB Moore |
Matrix biology : journal of the International Society for Matrix Biology | 2018 |
Disparate Remodeling of the Extracellular Matrix and Proteoglycans in Failing Pediatric Versus Adult Hearts
S Jana, H Zhang, GD Lopaschuk, DH Freed, C Sergi, PF Kantor, GY Oudit, Z Kassiri |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2018 |
Ninjurin1 Plays a Crucial Role in Pulmonary Fibrosis by Promoting Interaction between Macrophages and Alveolar Epithelial Cells
S Choi, JK Woo, YS Jang, JH Kang, JI Hwang, JK Seong, YS Yoon, SH Oh |
Scientific Reports | 2018 |